Title: Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis
Abstract: ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Jura-Szołtys E, Gawlik R, Branicka O, Stryjewska-Makuch G, Glück J. Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis. Postępy Dermatologii i Alergologii/Advances in Dermatology and Allergology. 2022. doi:10.5114/ada.2022.117978. APA Jura-Szołtys, E., Gawlik, R., Branicka, O., Stryjewska-Makuch, G., & Glück, J. (2022). Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis. Postępy Dermatologii i Alergologii/Advances in Dermatology and Allergology. https://doi.org/10.5114/ada.2022.117978 Chicago Jura-Szołtys, Edyta, Radosław Gawlik, Olga Branicka, Grażyna Stryjewska-Makuch, and Joanna Glück. 2022. "Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis". Postępy Dermatologii i Alergologii/Advances in Dermatology and Allergology. doi:10.5114/ada.2022.117978. Harvard Jura-Szołtys, E., Gawlik, R., Branicka, O., Stryjewska-Makuch, G., and Glück, J. (2022). Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis. Postępy Dermatologii i Alergologii/Advances in Dermatology and Allergology. https://doi.org/10.5114/ada.2022.117978 MLA Jura-Szołtys, Edyta et al. "Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis." Postępy Dermatologii i Alergologii/Advances in Dermatology and Allergology, 2022. doi:10.5114/ada.2022.117978. Vancouver Jura-Szołtys E, Gawlik R, Branicka O, Stryjewska-Makuch G, Glück J. Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis. Postępy Dermatologii i Alergologii/Advances in Dermatology and Allergology. 2022. doi:10.5114/ada.2022.117978.